Is Ajooni Biotech a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ajooni Biotech Ltd is a below average quality company .

Is Ajooni Biotech undervalued or overvalued?

The key valuation ratios of Ajooni Biotech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Ajooni Biotech share price return in the past 10 years?

Data is not available for this company

Is Ajooni Biotech a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Ajooni Biotech Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

Ajooni Biotech Ltd - Stock Valuation and Financial Performance

Name: Ajooni Biotech
Brand: Ajooni Biotech

BSE: 0 | NSE: AJOONI | Animal Feed | Small Cap

Place order

BSE Share Price
Not Listed

10 Year X-Ray of Ajooni Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	4.5%	19%	12.8%	25.4%	7.2%	1.9%	2.9%	3.6%	6.5%	4.3%	-
Value Creation Index ⓘ	-0.7	0.4	-0.1	0.8	-0.5	-0.9	-0.8	-0.7	-0.5	-0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.6	7.2	13.2	28.5	42.4	39.7	40	51	74	74.5	102
Sales YoY Gr.	-	1,164.9%	83.5%	115.7%	48.5%	-6.3%	0.8%	27.5%	45.1%	0.6%	-
Adj EPS ⓘ	0	0.2	0.3	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1
YoY Gr.	-	900%	35%	100%	-77.8%	-41.7%	0%	0%	200%	-38.1%	-
BVPS (₹) ⓘ	1	1.2	1.5	1.9	3.2	3.4	3.3	3.1	3.3	4.8	5
Adj Net Profit ⓘ	0	0.1	0.1	0.3	0.4	0.2	0.3	0.4	1.1	1.1	2
Cash Flow from Ops. ⓘ	-0.1	0.2	-0.6	0	0	-4.9	-4.4	1.2	3.7	-5.6	-
Debt/CF from Ops. ⓘ	0	0	-1.3	0	0	-1	-1.2	5.9	1.5	-0.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	71.8%	12%	23%	0.6%
Adj EPS ⓘ	23.1%	1.6%	22.9%	-38.1%
BVPSⓘ	19.2%	8.3%	12.5%	45.6%
Share Price	-	-17.6%	-48.2%	20.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	4.3	18.7	20.4	36.6	6.3	1.9	2.3	2.4	6.6	3.9	2.1
Op. Profit Mgn % ⓘ	2.1	1.8	1.7	2.3	2.2	1.8	3.1	3.2	4.2	3.7	1.6
Net Profit Mgn % ⓘ	1.4	1	0.7	1	0.9	0.6	0.8	0.7	1.4	1.5	1.7
Debt to Equity ⓘ	0	0	1.5	0.6	0.5	0.4	0.3	0.4	0.3	0.1	0
Working Cap Days ⓘ	128	43	46	51	53	85	135	138	106	171	149
Cash Conv. Cycle ⓘ	43	5	12	2	17	58	103	98	64	73	92

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 23.00%

Net Profit is growing at healthy rate in last 3 years 22.92%

Sales growth is good in last 4 quarters at 87.42%

Return on Equity has declined versus last 3 years average to 2.10%

Latest Financials - Ajooni Biotech Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.1	-
TTM Sales (₹ Cr.)	102	-
BVPS (₹.) ⓘ	5	-
Reserves (₹ Cr.) ⓘ	52	-
P/BV ⓘ	1.30	-
PE ⓘ	63.25	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	113
Equity (₹ Cr.)	35.1
Face Value (₹)	2
Industry PE ⓘ	29.8

Management X-Ray of Ajooni Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Ajooni Biotech

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Ajooni Biotech

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	1	7	13	29	42	40	40	51	74	74
Operating Expenses ⓘ	1	7	13	28	41	39	39	49	71	72
Manufacturing Costs	0	0	0	0	1	1	1	1	1	1
Material Costs	0	6	11	24	38	36	35	43	64	66
Employee Cost	0	0	0	1	1	1	1	1	1	2
Other Costs ⓘ	0	1	1	3	2	1	2	4	4	3
Operating Profit ⓘ	0	0	0	1	1	1	1	2	3	3
Operating Profit Margin (%)	2.1%	1.8%	1.7%	2.3%	2.2%	1.8%	3.0%	3.2%	4.2%	3.7%
Other Income ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	1	1	0
Depreciation ⓘ	0	0	0	0	0	0	0	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	0	0	0	0	0	1	1	2
Tax ⓘ	0	0	0	0	0	0	0	0	0	0
Profit After Tax	0	0	0	0	0	0	0	0	1	1
PAT Margin (%)	1.4%	1.0%	0.7%	1.0%	0.9%	1.0%	0.9%	0.7%	1.4%	1.5%
Adjusted EPS (₹)	0.0	0.2	0.3	0.6	0.1	0.1	0.1	0.1	0.2	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	0	0	1	1	11	12	16	16	16	42
Share Capital ⓘ	0	0	0	0	6	6	8	10	10	18
Reserves ⓘ	0	0	0	1	5	6	7	6	6	24
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	1	1	5	5	5	6	4	5
Long Term Debt	0	0	0	1	0	4	1	2	3	2
Short Term Debt	0	0	1	0	4	1	4	4	2	3
Trade Payables	0	1	1	5	1	1	2	5	7	10
Others Liabilities ⓘ	0	0	0	6	3	0	0	1	1	2
Total Liabilities ⓘ	0	2	2	13	19	18	23	28	29	58
Fixed Assets
Gross Block	0	0	0	1	2	2	3	5	9	10
Accumulated Depreciation	0	0	0	0	1	1	1	2	3	4
Net Fixed Assetsⓘ	0	0	0	1	1	1	2	4	6	6
CWIP ⓘ	0	0	0	0	0	0	0	2	0	0
Investmentsⓘ	0	0	0	6	6	4	3	1	1	4
Inventories	0	0	0	4	2	5	3	5	6	7
Trade Receivables	0	1	1	1	3	5	13	14	14	21
Cash Equivalents	0	0	0	0	5	1	0	0	0	0
Others Assetsⓘ	0	0	0	0	2	3	2	2	2	20
Total Assets ⓘ	0	2	2	13	19	18	23	28	29	58

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'16	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0	-1	-5	-4	1	4	-6
PBT ⓘ	0	0	0	0	1	1	2
Adjustment ⓘ	0	0	0	1	1	2	1
Changes in Working Capital ⓘ	-0	-1	-6	-5	-0	1	-8
Tax Paid ⓘ	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	0	0	1	0	-3	-2	-16
Capex	0	0	2	0	-4	-2	-3
Net Investments	0	0	-1	0	0	0	-13
Others ⓘ	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0	1	-1	3	2	-2	22
Net Proceeds from Shares ⓘ	0	0	1	3	1	0	22
Net Proceeds from Borrowing ⓘ	0	0	2	-3	1	1	-1
Interest Paid ⓘ	0	0	0	0	-1	-1	0
Dividend Paid ⓘ	0	0	0	0	0	0	0
Others ⓘ	0	1	-4	3	1	-2	1
Net Cash Flow ⓘ	0	0	-5	-1	0	0	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	N/A	N/A	20.38	36.98	6.8	3.72	2.54	2.4	6.58	3.87
ROCE (%)	N/A	N/A	18.62	36.19	10.03	3.84	4.35	5.07	9.09	5.99
Asset Turnover Ratio	2.25	6.83	6.56	3.74	2.64	2.12	1.95	2.01	2.61	1.71
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	4	-6
Working Capital Days
Receivable Days	60	22	28	16	18	35	80	94	68	84
Inventory Days	109	13	11	30	27	32	38	31	28	32
Payable Days	52	37	31	45	30	10	16	31	35	47

Ajooni Biotech Ltd Stock News

Ajooni Biotech Ltd FAQs

What is the share price of Ajooni Biotech?

Company share prices are keep on changing according to the market conditions. The closing price of Ajooni Biotech on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Ajooni Biotech?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Ajooni Biotech stood at ₹113.0.